Stammdaten
Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.
Unternehmen & Branche
| Name | Aclarion, Inc. |
|---|---|
| Ticker | ACON |
| CIK | 0001635077 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Medical - Healthcare Information Services |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 1,8 Mio. USD |
| Beta | 1,14 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 75,730 | -7,233,629 | -13.61 | 13,672,404 | 12,835,117 |
| 2025-09-30 | 10-Q | 18,942 | -1,706,294 | -2.93 | 13,200,298 | 12,500,551 |
| 2025-06-30 | 10-Q | 19,319 | -1,600,757 | -2.75 | 14,754,520 | 14,190,098 |
| 2025-03-31 | 10-Q | 18,991 | -2,037,436 | -9.32 | 16,479,677 | 15,780,645 |
| 2024-12-31 | 10-K | 45,724 | -6,992,927 | -###.## | 2,123,483 | 970,057 |
| 2024-09-30 | 10-Q | 14,407 | -1,366,176 | -###.## | 3,188,052 | 2,509,785 |
| 2024-06-30 | 10-Q | 10,971 | -1,238,077 | -###.## | 3,088,821 | 1,642,177 |
| 2024-03-31 | 10-Q | 10,114 | -2,399,102 | -###.## | 3,727,262 | 2,505,449 |
| 2023-12-31 | 10-K | 75,404 | -4,911,374 | -###.## | 2,459,774 | -727,995 |
| 2023-09-30 | 10-Q | 19,065 | -998,010 | -1.87 | 1,543,219 | -827,980 |
| 2023-06-30 | 10-Q | 17,072 | -1,464,557 | -2.83 | 2,004,466 | 10,223 |
| 2023-03-31 | 10-Q | 25,470 | -1,183,460 | -2.39 | 1,861,437 | 1,125,029 |
| 2022-12-31 | 10-K | 60,444 | -7,068,593 | -19.61 | 2,914,629 | 2,225,958 |
| 2022-09-30 | 10-Q | 18,222 | -1,633,033 | -0.20 | 4,101,162 | 2,932,737 |
| 2022-06-30 | 10-Q | 10,676 | -3,554,862 | -0.47 | 5,620,989 | 4,239,570 |
| 2022-03-31 | 10-Q | 9,026 | -936,088 | -1.35 | 1,807,990 | -14,031,887 |
| 2021-12-31 | 10-K | 60,292 | -4,950,290 | -6.58 | 1,889,465 | -12,831,606 |
| 2021-09-30 | 10-Q | 10,865 | -2,952,418 | -3.58 | -11,612,424 | |
| 2021-06-30 | 10-Q | 25,620 | -465,844 | -8,453,285 | ||
| 2021-03-31 | 10-Q | 11,830 | -517,860 | -7,802,493 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.